Reali Kenneth Michael's Form 4/A amendment
AmendedBioventus Inc. (BVS) · filed Apr 21, 2023
- Accession no.
- 0001578563-23-000024
- Filed
- Apr 21, 2023
- Trade date
- Mar 14, 2022
- Filing delay
- 403 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Mar 16, 2023
This filing lists 1 derivative transaction. It carries over 3 transactions from the original filing that it did not restate. Open-market sales total $13.6K. It was filed 403 days after the trade.
This amendment restates part of 0000899243-23-008792 (filed Mar 16, 2023). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reali Kenneth MichaelCIK 0001480801 | Director, Officer (Fmr. CEO and Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2022 | Class A Common Stock | AGrant or awardAcquired | +466,054 | $0.00 | $0 | 466,054 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0000899243-23-008792 (filed Mar 16, 2023).
Non-derivative securities (Table I)
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2023 | Class A Common Stock | MOption exerciseDisposed | −28,721 | $0.00 | $0 | 86,161 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $1.37 to $1.43, inclusive. Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The options shall vest in four approximately equal installments on each of the first four anniversaries of March 14, 2022, in each case subject to the Reporting Person continuing in service through the applicable vesting date.
Remarks
This Form 4 amendment is being filed to report the acquisition of stock options that were inadvertently omitted from the original filing.